Cargando…
A Glycolipid α-GalCer Derivative, 7DW8-5 as a Novel Mucosal Adjuvant for the Split Inactivated Influenza Vaccine
Influenza virus infects the host and transmits through the respiratory tract (i.e., the mouth and nose); therefore, the development of intranasal influenza vaccines that mimic the natural infection, coupled with an efficient mucosal adjuvant, is an attractive alternative to current parenteral vaccin...
Autores principales: | Feng, Huapeng, Sun, Ruolin, Song, Guanru, Zhu, Shunfan, Nie, Zhenyu, Lin, Liming, Yi, Ruonan, Wu, Shixiang, Wang, Genzhu, He, Yulong, Wang, Siquan, Wang, Pei, Wu, Li, Shu, Jianhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230830/ https://www.ncbi.nlm.nih.gov/pubmed/35746644 http://dx.doi.org/10.3390/v14061174 |
Ejemplares similares
-
Synthesis of a 2''-Deoxy-β-GalCer
por: Thakur, Meena S., et al.
Publicado: (2014) -
KAP1 Positively Modulates Influenza A Virus Replication by Interacting with PB2 and NS1 Proteins in Human Lung Epithelial Cells
por: Feng, Huapeng, et al.
Publicado: (2022) -
A Multifactorial Mechanism in the Superior Antimalarial Activity of α-C-GalCer
por: Schmieg, John, et al.
Publicado: (2010) -
Interaction between Bacteria and the Immune System for Cancer Immunotherapy: The α-GalCer Alliance
por: Ustjanzew, Arsenij, et al.
Publicado: (2022) -
Galactosylsphingamides: new α-GalCer analogues to probe the F’-pocket of CD1d
por: Guillaume, Joren, et al.
Publicado: (2017)